Department of Health (DOH) Minister Yaung Chih-liang (楊志良) said recently that we cannot directly link death after treatment with the vaccine for A(H1N1) influenza to the vaccine itself and that further studies are needed.
Since this involves the risks posed by vaccinations, the ministry should explain the risks to the public and take proper precautions.
Earlier last month, a New York Times editorial said the US government took a series of steps to prepare for a potential A(H1N1) pandemic. Public officials were instructed to stockpile antiviral drugs. When a swine flu case emerged in April, diagnostic kits to detect the virus were created for use nationwide and domestic companies were enrolled to make the vaccine.
In addition, the government signed contracts with several farmers in Pennsylvania and requisitioned their eggs to grow flu vaccine.
By the middle of next month, the US will have at least 80 million doses ready for a mass immunization program. It seems everything has proceeded smoothly and is under control.
However, the weakest link in this chain of preparations is the federal bureaucracy’s head-in-the-sand attitude toward explaining the risks of the vaccination program to the public, which may cause all those efforts to come to naught.
In Taiwan, this is reflected in the DOH’s torpor in informing the public of any risks posed by flu vaccine, despite repeated assurances that domestically produced flu vaccines are safe and effective.
Some risks posed by treatment with the flu vaccine are predictable.
The real controversy, however, will not appear until after the health authorities begin administering flu vaccinations on a large scale this fall and winter.
The DOH will issue 10 million doses of the vaccine, three times the number of people receiving seasonal influenza vaccines in previous years.
That being the case, the probabilities of side effects caused by the vaccine will increase significantly.
In 1976, one in 100,000 people in the US who received the H1N1 flu vaccine suffered from side effects, developing Guillain-Barre syndrome — a crippling nerve disorder that caused many deaths. Some academics argue that it might have been related to the antigen in vaccines or toxins in contaminated germs during the manufacturing process.
Will similar reactions be seen in Taiwan following the implementation of a mass vaccination program?
Statistically speaking, it is inevitable that some of the nearly 1 million people receiving vaccines this fall will become ill or die.
If anyone happens to get ill or die after being vaccinated, it will likely be the result of underlying health problems, although the vaccine will often be blamed.
For example, pregnant women infected with swine flu are four times more likely to become severely ill or die than ordinary people.
But statistics show that about one in seven pregnancies ends in a miscarriage. Thus, after pregnant women get the vaccine, a miscarriage may coincidentally happen. Some will likely attribute it to the vaccine.
Now that the DOH has given pregnant women priority for the future flu vaccine program, a major controversy could ensue.
If this were to happen, it would certainly turn into a political storm.
Public health officials should be prepared.
Liou Pei-pai is a former director of the Taiwan Animal Health Research Institute.
TRANSLATED BY TED YANG
Chinese President Xi Jinping (習近平) has prioritized modernizing the Chinese People’s Liberation Army (PLA) to rival the US military, with many experts believing he would not act on Taiwan until the PLA is fully prepared to confront US forces. At the Chinese Communist Party’s 20th Party Congress in 2022, Xi emphasized accelerating this modernization, setting 2027 — the PLA’s centennial — as the new target, replacing the previous 2035 goal. US intelligence agencies said that Xi has directed the PLA to be ready for a potential invasion of Taiwan by 2027, although no decision on launching an attack had been made. Whether
A chip made by Taiwan Semiconductor Manufacturing Co (TSMC) was found on a Huawei Technologies Co artificial intelligence (AI) processor, indicating a possible breach of US export restrictions that have been in place since 2019 on sensitive tech to the Chinese firm and others. The incident has triggered significant concern in the IT industry, as it appears that proxy buyers are acting on behalf of restricted Chinese companies to bypass the US rules, which are intended to protect its national security. Canada-based research firm TechInsights conducted a die analysis of the Huawei Ascend 910B AI Trainer, releasing its findings on Oct.
In honor of President Jimmy Carter’s 100th birthday, my longtime friend and colleague John Tkacik wrote an excellent op-ed reassessing Carter’s derecognition of Taipei. But I would like to add my own thoughts on this often-misunderstood president. During Carter’s single term as president of the United States from 1977 to 1981, despite numerous foreign policy and domestic challenges, he is widely recognized for brokering the historic 1978 Camp David Accords that ended the state of war between Egypt and Israel after more than three decades of hostilities. It is considered one of the most significant diplomatic achievements of the 20th century.
Pat Gelsinger took the reins as Intel CEO three years ago with hopes of reviving the US industrial icon. He soon made a big mistake. Intel had a sweet deal going with Taiwan Semiconductor Manufacturing Co (TSMC), the giant manufacturer of semiconductors for other companies. TSMC would make chips that Intel designed, but could not produce and was offering deep discounts to Intel, four people with knowledge of the agreement said. Instead of nurturing the relationship, Gelsinger — who hoped to restore Intel’s own manufacturing prowess — offended TSMC by calling out Taiwan’s precarious relations with China. “You don’t want all of